SEC Form 4 · accession 0001140361-16-054450
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven M. Nardi
Officer — VP of Manufacturing
Period of report
Feb 18, 2016
Accepted (ET)
Feb 22, 2016 · 7:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 18, 2016 | A | 2,188 | $1.48 | A | 2,288 | D | |
| Common Stock | Feb 18, 2016 | S | 192 | $17.00 | D | 2,096 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.48 | Feb 18, 2016 | M | 2,188 | D | — | Dec 31, 2020 | Common Stock | 2,188 | 4,999 | D |
Explanation of responses
- F1This option, representing a right to purchase a total of 4,375 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.